Dendritic catanionic assemblies:: In vitro anti-HIV activity of phosphorus-containing dendrimers bearing Galβ1cer analogues

被引:76
作者
Blanzat, M
Turrin, CO
Aubertin, AM
Couturier-Vidal, C
Caminade, AM
Majoral, JP
Rico-Lattes, I
Lattes, A
机构
[1] Univ Toulouse 3, Lab Interact Mol & React Chim & Photochim, CNRS, UMR 5623, F-31062 Toulouse, France
[2] CNRS, Chim Coordinat Lab, UPR 8241, F-31077 Toulouse, France
[3] Univ Strasbourg, Inst Virol, INSERM, U544, F-67000 Strasbourg, France
[4] Univ Toulouse 3, Serv Commun Informat Chim, F-31062 Toulouse, France
关键词
anti-HIV; catanionic amphiphiles; dendrimers; galactosylceramide; phosphorus;
D O I
10.1002/cbic.200500203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Two series of water-soluble dendritic cotanionic assemblies, acting as multisite analogues of galactosylceramide (Gal beta(1)cer), have been prepared with the goal of blocking HIV infection prior to the entry of the virus into human cells. Trifunctional and hexafunctional cinnamic acid-terminated dendrimers have been synthesized from phosphorus-containing dendrimers bearing aldehyde end groups. A classical acid-base reaction performed in water between acid-terminated dendrimers and stoichiometric amounts of N-hexodecylamino-1-deoxylactitol (3) provided the expected catanionic assemblies. Antiviral assays on these supramolecular entities confirmed the crucial roles both of multivalency effects and of lipophilicity on the biological activity of Gal beta(1)cer analogues. Moreover, correlation between in vitro tests and molecular modeling highlights the specific influence of the assembly shape on the anti-HIV efficiency, with the tri- and hexafunctional cored dendrimers, both decorated with 12 sugar moieties, exhibiting IC50 values of 1.1 and 0.12 mu m, respectively.
引用
收藏
页码:2207 / 2213
页数:7
相关论文
共 48 条
[1]
MOLECULAR APPROACHES FOR THE TREATMENT OF HEMORRHAGIC-FEVER VIRUS-INFECTIONS [J].
ANDREI, G ;
DECLERCQ, E .
ANTIVIRAL RESEARCH, 1993, 22 (01) :45-75
[2]
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[3]
CARBON-LINKED GALACTOSPHINGOLIPID ANALOGS BIND SPECIFICALLY TO HIV-1 GP120 [J].
BERTOZZI, CR ;
COOK, DG ;
KOBERTZ, WR ;
GONZALEZSCARANO, F ;
BEDNARSKI, MD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (26) :10639-10641
[4]
MALDI TOF mass spectrometry for the characterization of phosphorus-containing dendrimers. Scope and limitations [J].
Blais, JC ;
Turrin, CO ;
Caminade, AM ;
Majoral, JP .
ANALYTICAL CHEMISTRY, 2000, 72 (20) :5097-5105
[5]
Correlation between structure, aggregation behaviour and cellular toxicity of anti-HIV catanionic analogues of galactosylceramide [J].
Blanzat, M ;
Perez, E ;
Rico-Lattes, I ;
Lattes, A ;
Gulik, A .
CHEMICAL COMMUNICATIONS, 2003, (02) :244-245
[6]
Phosphorus-containing dendrimers bearing galactosylceramide analogs: Self-assembly properties [J].
Blanzat, M ;
Turrin, CO ;
Perez, E ;
Rico-Lattes, I ;
Caminade, AM ;
Majoral, JP .
CHEMICAL COMMUNICATIONS, 2002, (17) :1864-1865
[7]
New catanionic glycolipids.: 1.: Synthesis, characterization, and biological activity of double-chain and gemini catanionic analogues of galactosylceramide (galβ1cer) [J].
Blanzat, M ;
Perez, E ;
Rico-Lattes, I ;
Prome, D ;
Prome, JC ;
Lattes, A .
LANGMUIR, 1999, 15 (19) :6163-6169
[8]
Interaction between phospholipids and new Gemini catanionic surfactants having anti-HIV activity [J].
Brun, A ;
Brezesinski, G ;
Möhwald, H ;
Blanzat, M ;
Perez, E ;
Rico-Lattes, I .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2003, 228 (1-3) :3-16
[9]
Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry [J].
Fantini, J ;
Hammache, D ;
Delezay, O ;
Yahi, N ;
AndreBarres, C ;
RicoLattes, I ;
Lattes, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :7245-7252
[10]
Fischer M, 1999, ANGEW CHEM INT EDIT, V38, P885, DOI 10.1002/(SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO